Related by context. All words. (Click for frequent words.) 65 OvaRex ® MAb 64 MAGE A3 ASCI 63 Canvaxin 63 R sorafenib tablets 63 Tarceva TM 63 ospemifene 63 Nexavar sorafenib 63 IV Busulfex 63 vinflunine 63 Raptiva R 63 Raptiva ® 63 RhuDex ® 63 acyclovir Lauriad R 62 UPLYSO 62 ZACTIMA 62 Temodar ® 62 Pirfenidone 62 Vectibix panitumumab 62 Gleevec Glivec 62 Vantas 62 Cimzia TM 62 Velcade bortezomib 62 Plenaxis 61 thetreatment 61 Erbitux cetuximab 61 nasal calcitonin product 61 Proquin XR 61 Reclast Aclasta 61 Orencia abatacept 61 alvespimycin 61 cetuximab Erbitux 61 Troxatyl 61 YONDELIS R 61 EOquin TM 61 Aviptadil 61 Amrubicin 61 demonstrated antitumor activity 61 YONDELIS 61 Modrenal R 61 Cellegesic 60 Proellex TM 60 Rapinyl 60 RELISTOR ® 60 metastatic bladder 60 Vimpat ® lacosamide 60 RoACTEMRA 60 Dacogen injection 60 Evoltra ® 60 Campto 60 apaziquone 60 Alimta pemetrexed 60 Virulizin 60 compound KOS 60 Silodosin 60 Zavesca r 60 telomerase therapeutic 60 ovarian breast 60 Certican 60 ELIQUIS 59 Prestara 59 G#DT 59 Argatroban 59 PrevOnco 59 Orapred ODT 59 BioNumerik 59 TYZEKA 59 Ethyol 59 KNS # 59 Afatinib 59 malignant ascites 59 Tavocept 59 AZILECT ® 59 Insegia 59 volociximab 59 IV APAP 59 Nexavar tablets 59 Campath ® 59 Proleukin 59 Uvidem 59 rufinamide 59 Annamycin 59 Abbokinase 59 Aplidin 59 Theratope 59 oral dual endothelin 59 Loramyc R 58 Cancidas 58 Orathecin 58 neratinib 58 KRAS mutated 58 pain palliation 58 NB S# strontium malonate 58 Keppra ® levetiracetam 58 LymphoStat B belimumab 58 Targretin capsules 58 Canvaxin TM 58 CONBRIZA 58 Nycomed GmbH 58 TBC# 58 Ceflatonin 58 Zirgan 58 Soliris TM eculizumab 58 incyclinide 58 Zemplar Capsules 58 Zentaris 58 Cx# [002] 58 VALSTAR TM 58 CIMZIA r 58 CTAP# Capsules 58 ZALBIN 58 lumiliximab 58 Tyzeka Sebivo 58 olanzapine LAI 58 Serdolect 58 SNT MC# 58 gepirone ER 58 secondary amenorrhea 58 ularitide 58 Onalta 58 GVAX ® 58 vidofludimus 58 Mipomersen 58 Oncophage vitespen 58 DepoDur 58 lung pancreatic 58 Alzhemed TM 57 Gleevec imatinib mesylate 57 ACEON R 57 TheraCIM h R3 57 Oncogenex 57 follicular Non Hodgkin 57 LEVADEX ™ 57 MabThera Rituxan 57 Rigel Pharmaceuticals Inc 57 BENLYSTA ® 57 Onalta ™ 57 GRNVAC1 57 OMAPRO ™ 57 Civacir 57 ZEFTERA TM Zevtera TM 57 Cetrotide R 57 cediranib 57 Archexin 57 POSIDUR TM 57 Pazopanib 57 Enbrel etanercept 57 Albugon 57 Astellas Deutschland GmbH 57 Vicinium TM 57 LHRH antagonist 57 Gelclair 57 Virulizin ® 57 Onalta TM 57 Zenapax 57 amrubicin 57 Aurograb 57 reslizumab 57 Somatuline Autogel 57 Angiox ® 57 Retacrit 57 enzastaurin 57 Phase IIIb clinical 57 Zybrestat 57 romidepsin 57 OvaRex R 57 Multiferon 57 IMA# 57 briakinumab 57 Tracleer r 57 Testim R 57 ridaforolimus 57 relapsed leukemia 57 Trofex TM 57 radiotherapeutic 57 terlipressin 56 oral PTH 56 Neupro patch 56 TKM PLK1 56 AML acute myeloid 56 commercialize deforolimus 56 Vernalis plc 56 Hectorol 56 Troxatyl TM 56 mSEPT9 biomarker 56 receptor tyrosine kinase inhibitor 56 ZYFLO R 56 VNP#M 56 Oasmia 56 Humira adalimumab 56 Fortigel 56 Rectogesic 56 methylnaltrexone 56 ONTAK 56 elotuzumab 56 L BLP# 56 Loramyc 56 psoriasis rheumatoid arthritis 56 MERREM 56 Darinaparsin 56 Mesafem 56 refractory acute myeloid 56 adjuvant colon cancer 56 EGRIFTA TM 56 Pyridorin 56 TheraCIM 56 Phase IIb III 56 smoldering myeloma 56 galiximab 56 elacytarabine 56 MCSP respectively 56 skeletal metastases 56 candidate epratuzumab 56 kidney urologic 56 PROSTVAC ® 56 Removab 56 Lovaza TM 56 supplemental biologics 56 oral picoplatin 56 Solazed 56 TREANDA 56 commercialize elagolix 56 CellCept mycophenolate mofetil 56 NASDAQ PHRM 56 5 lipoxygenase inhibitor 56 DPX Survivac 56 tiapamil 56 Nimotuzumab 56 Manja Bouman CEO 56 JOULFERON 56 Apokyn ® 56 Taiho Pharmaceutical 56 HuMax CD4 56 CIMYM 56 Bendamustine 56 estramustine 56 Avastin adjuvant 56 huC# DM4 56 ASA# 56 Somatuline 55 Preotact 55 CDP# 55 commercializes oncology 55 RSD# oral 55 topical NSAID 55 oncological indications 55 successfully commercialize Iluvien 55 Loramyc ® 55 OZURDEX ® 55 Striant 55 ocrelizumab 55 Thelin tm 55 ATL# [002] 55 Xinlay 55 farletuzumab 55 Xcytrin R 55 lintuzumab SGN 55 Oncaspar 55 haematological malignancies 55 Somatuline R Autogel R 55 PEG SN# 55 Yentreve 55 Fortical R 55 including eniluracil ADH 55 Memryte 55 DNA methylation biomarker 55 Aurexis 55 Icatibant 55 tanespimycin 55 regorafenib 55 danoprevir 55 PROVIGIL 55 oxypurinol 55 Rezonic 55 Myfortic 55 tramiprosate Alzhemed TM 55 BEXXAR 55 Kissei Pharmaceutical 55 ATryn ® 55 cMET 55 Pimavanserin 55 DepoDur R 55 DCVax R Brain 55 Rhucin ® recombinant 55 neovascular diseases 55 EP #R 55 elinogrel 55 ruxolitinib 55 Folotyn 55 rheumatoid arthritis psoriatic arthritis 55 Savene ® 55 gabapentin enacarbil 55 oncologic diseases 55 hepatitis C HCV 55 SYN# 55 CINOD 55 PROSTVAC TM 55 TransMID TM 55 valtorcitabine 55 Asentar 55 Quark Biotech 55 Satraplatin 55 Merck Sante sas 55 catheter occlusion 55 GRN# 55 BrachySil 55 delay bone metastases 55 Lupuzor 55 mitiglinide 55 acetonide FA 55 locoregional recurrence 54 Orazol 54 registrational 54 Urocidin TM 54 ticagrelor Brilinta 54 iniparib 54 ATG Fresenius S 54 FOLOTYN 54 tubulin inhibitor 54 haematologic 54 Fusilev 54 Ceflatonin R 54 hereditary deficiency 54 MyVax ® 54 Pancreas Cancer Vaccine 54 phase IIb trial 54 Holding AG ROG.VX 54 nabilone 54 Urocidin 54 pomalidomide 54 injectable formulations 54 Apoptone 54 autoimmune indications 54 Generx TM 54 HuMax TAC 54 Fibrillex 54 Cethrin 54 valopicitabine 54 PrevOnco ™ 54 lurasidone 54 PDE# inhibitors 54 candidates Dyloject TM 54 investigational therapies 54 indiplon capsules 54 novel therapeutic antibodies 54 humanised monoclonal antibody 54 OMP designation 54 MGN# 54 budesonide foam 54 myeloproliferative neoplasms MPNs 54 Nabi HB 54 RTP #i 54 Anidulafungin 54 AZX# 54 Angiox 54 Orphan Drug status 54 Iluvien ® 54 Phase #/#a trial 54 zileuton tablets 54 Vitaxin 54 S/GSK# 54 myeloproliferative disorders 54 Nanobody R 54 Combidex 54 fesoterodine 54 TRAIL receptor antibodies 54 mGluR5 NAM 54 Nippon Kayaku 54 Azmacort R 54 StemEx R 54 theranostic 54 cephalosporin antibiotic 54 investigational compounds 54 Rhucin R 54 lymphomas leukemias 54 Ceflatonin ® 54 fusion enhancers 54 Aphthasol R 54 Crofelemer budesonide foam 54 Davanat 54 severe hypersensitivity reactions 54 Tectin TM 54 axitinib 54 DepoCyt 54 Roche OTC RHHBY 54 Sanctura 54 eprodisate KIACTA TM 54 Cinquil 54 taxane refractory 54 Pierre Fabre Medicament 54 Aclasta Reclast 54 Zemiva TM 54 Fabry Disease 54 osteolytic bone disease 54 HQK 54 Kosan motilin agonist 54 reteplase 54 DC Bead 54 Benlysta belimumab 54 compound INCB# 54 TNF blocker therapy 54 Nippon Shinyaku 54 GlaxoSmithKline Biologicals SA 54 Corlux 54 Gelclair R 54 vemurafenib 54 CYT# vascular disrupting 54 sodium stibogluconate 54 Sudhir Agrawal D.Phil 54 novel oral anticoagulant 54 Esbriet pirfenidone 54 taliglucerase alfa 54 NP2 Enkephalin 54 XIAFLEX ™ 54 Neupro ® 53 CYT# NicQb 53 Stanate R 53 canakinumab 53 ritonavir boosted danoprevir 53 Valdoxan 53 inhaled iloprost 53 voclosporin 53 Apokyn 53 Colon polyps 53 Napo Pharmaceuticals 53 Firdapse 53 regadenoson 53 CytoFab 53 Survivin antagonist 53 www.soliris.net 53 Fibrillex TM 53 BNC# 53 GEM #S 53 Multiferon R 53 NSABP C 53 lenalidomide dexamethasone 53 mGluR4 PAM 53 calcineurin inhibitors 53 Nanobody 53 Angiox R 53 RECOTHROM ® 53 talactoferrin 53 liver resection surgeries 53 commercialize MDV# 53 phase IIb study 53 GLASSIA 53 Pharmion Corporation 53 IMiDs 53 ImmunoGen TAP technology 53 Berinert 53 Meda AB 53 Uracyst 53 Reata Pharmaceuticals 53 Merck KGaA Erbitux 53 lixivaptan 53 novel trazodone formulation 53 HepeX B 53 cSSTI 53 Nasdaq MITI biopharmaceutical 53 vosaroxin 53 Orphan Drug designations 53 Veronate 53 MOZOBIL 53 eculizumab therapy 53 StemEx 53 COMFORT II 53 oral prodrug 53 Cerashield 53 pediatric malignancies 53 faropenem 53 investigational monoclonal antibody 53 Zeneus 53 ADVEXIN clinical 53 velafermin 53 bardoxolone 53 anti EGFR antibody 53 VIBEX MTX 53 mitoxantrone concentrate 53 phase IIa 53 squalamine 53 PROCHYMAL 53 Apokyn R 53 urocortin 2 53 GVAX 53 photodynamic treatment 53 Li Fraumeni Syndrome 53 Scancell 53 Targeted Chemotherapy 53 tetrabenazine 53 StromaCel Inc. 53 sodium thiosulfate STS 53 Zoraxel 53 Joulferon 53 AVERROES 53 bendamustine HCl 53 OXi# 53 Increlex TM 53 BEMA TM LA 53 DOV Pharmaceutical 53 Allos retains exclusive 53 bardoxolone methyl 53 Mycograb 53 delivers fluocinolone acetonide FA 53 TRIOLEX HE# APOPTONE HE# 53 Hedgehog antagonist 53 EVICEL 53 treatmentof 53 Plenaxis R 53 6R BH4 53 refractory Hodgkin 52 shingles vaccine Zostavax 52 immunotherapeutic approaches 52 Oncoscience 52 apricitabine 52 commercialize taliglucerase alfa 52 ZFP Therapeutics 52 cefixime 52 Oglemilast 52 Crofelemer 52 Syndrome LEMS 52 Shigamabs ® 52 Nabi HB R 52 endothelin antagonist 52 VEGF inhibitors 52 K ras mutations 52 Aton Pharma Inc. 52 HGS ETR2 52 Tibotec Pharmaceuticals Ltd. 52 Medidur FA 52 RH1 52 Teflaro 52 olaparib 52 Accentia Biopharmaceuticals 52 DepoBupivacaine TM 52 proteasome inhibitor 52 Indaflex 52 BCR ABL inhibitors 52 rALLy 52 HepaGam B R 52 European Medicines Evaluation 52 highly selective adenosine 52 immunological diseases 52 Proteo 52 nucleoside analogs 52 phase IIa clinical 52 candidate deforolimus 52 LymphoStat B 52 taxane resistant 52 dirucotide MBP# 52 Trilipix 52 Cabrellis Pharmaceuticals 52 unoprostone isopropyl 52 Stimuvax R 52 Nabi HB Intravenous 52 Rotarix R 52 fampridine SR 52 oral antiplatelet agent 52 SIMPONI TM 52 CoTherix 52 Silenor ® doxepin 52 samalizumab 52 tuberous sclerosis TS 52 AzaSite TM 52 Allovectin 7 ® 52 Phenoptin 52 Aggrastat 52 lorvotuzumab mertansine 52 Locteron exclusively 52 Oncoscience AG 52 Trovax 52 Simdax 52 leading oral taxane 52 neuropsychiatric adverse 52 TroVax ® 52 SUMAVEL 52 IMC #F# 52 Activase 52 rFactor XIII 52 induced tumor regression 52 Helsinn Healthcare 52 Norgine BV 52 RHEI Pharmaceuticals 52 cyclophilin inhibitors 52 gastrointestinal disorders ATI 52 calcineurin inhibitor 52 Oxiplex 52 Simponi golimumab 52 omacetaxine 52 plerixafor 52 Vibativ 52 Betaferon Betaseron 52 Rescula 52 Nanocort 52 darinaparsin Zinapar TM 52 CA9 SCAN 52 Evicel 52 leukaemias 52 Evoltra TM 52 acadesine 52 cannabinor 52 rALLy trial 52 RRMS patients 52 clofarabine 52 myeloproliferative diseases 52 PentaStaph 52 Lixivaptan 52 rhC1INH 52 triglyceride lowering 52 Gentamicin Surgical Implant 52 rThrombin 52 Ziopharm 52 Acute Radiation Syndrome ARS 52 AmpliMed 52 hepatitis B immune globulin 52 nalbuphine ER 52 HGS ETR1 mapatumumab 52 motesanib 52 vaccine Fluarix 52 Vertex retains 52 Metabasis Therapeutics 52 ocular formulation 52 phase Ib 52 CRINONE R 51 luliconazole 51 aerosolized AAT 51 HYVISC R 51 NeutroSpec TM 51 TELCYTA 51 TransVax TM 51 Akt inhibitor 51 gastrointestinal mucositis 51 Loramyc ™ 51 LidoPAIN SP 51 ELND# 51 Gattex 51 Glassia 51 TOCOSOL Camptothecin 51 Enbrel rheumatoid arthritis 51 Galderma SA 51 ecallantide 51 Evithrom 51 Budesonide foam crofelemer 51 Provectus Pharmaceuticals specializes 51 cardiovascular ischemic 51 ARIKACE ™ 51 UCB Pharma SA 51 Sigma Tau SpA 51 Schering Plough Corp SGP.N 51 BRAF V# mutation 51 Solasia 51 pafuramidine maleate 51 Phase Ib study 51 Novartis NVS Snapshot Report 51 Loramyc TM 51 painkiller Prexige 51 MyVax 51 ProLindac 51 monoclonal antibody therapeutics 51 ozarelix 51 Xigris 51 anti angiogenic agents 51 Gruenenthal 51 Wellstat 51 hypoxia activated prodrug 51 E2F Decoy 51 imexon 51 Taiho Pharmaceutical Co. 51 riociguat 51 grade serous ovarian 51 Invicorp R 51 HepaGam B 51 CELVAPAN H#N# 51 EGFR mutation positive 51 ALB # 51 Rotarix ® 51 IIa trials 51 Fast Track designations 51 riluzole 51 VELCADE novel 51 solanezumab 51 gastro intestinal inflammation 51 Rhucin ® 51 LHRH analogues 51 T DM1 51 tamibarotene 51 basiliximab 51 acute HAE attacks 51 oral RSD# 51 Falk Pharma 51 recombinant biopharmaceutical 51 PRT# 51 romazarit 51 Sopherion 51 EndoTAG TM 51 Lu AA# 51 metastatic neuroendocrine tumors 51 AERx iDMS 51 Nicole Onetto MD 51 Tasimelteon 51 Zevtera 51 Behcet uveitis 51 rheumatoid arthritis psoriasis 51 IIa clinical trial 51 adipiplon 51 REMICADE ® 51 breast cancer pill Tykerb 51 NASDAQ DCTH 51 AQ4N 51 fostamatinib disodium 51 evaluating Prochymal 51 trademarks Vitrasert R 51 MEK inhibitors 51 REMUNE R 51 drug ISA# 51 Veregen ® 51 Millennium Velcade 51 AGGRASTAT ® tirofiban hydrochloride 51 dermatology therapies 51 TÎ ² 4 51 KRAS status 51 Tasigna prolongs 51 Entereg R 51 angioedema indications 51 Flutiform TM 51 vismodegib 50 statistically significant superiority 50 Phase 2b clinical trials 50 IGF IR 50 Alequel 50 treat enlarged prostate 50 ANCHOR trial 50 mTOR inhibition 50 commercialize apixaban 50 Isotechnika Pharma 50 ponatinib 50 Seikagaku 50 HyQ 50 proprietary radiolabeled monoclonal 50 Selective Electrochemical Tumor Ablation 50 tumor necrosis 50 Fresenius Biotech 50 SOM# 50 ZADAXIN 50 Voraxaze ™ 50 Genentech Roche 50 tremelimumab 50 betrixaban 50 rheumatoid arthritis psoriasis Crohn 50 VaxImmune 50 haematological cancers 50 vernakalant oral 50 Combivir Kivexa 50 cognitive impairment associated 50 Exelixis compounds 50 Roche SWX ROG 50 Estrasorb 50 multitargeted 50 Liposomal Grb 2 50 CR# vcMMAE 50 omega interferon 50 phase 2a 50 Elafin 50 imatinib resistance 50 PNH patients 50 JP-#/fipamezole 50 Relovair 50 Kalbitor 50 Electronic Brachytherapy System 50 rindopepimut 50 Proxinium 50 Torsades de Pointes 50 Prometheus Laboratories 50 AMPK activators 50 Vegenics 50 commercialize OncoGenex lead 50 dexanabinol 50 hypervascular tumors 50 targeting miR 50 BLA filing 50 GLPG# 50 Periowave TM Photodisinfection System 50 efficacy tolerability 50 drug belatacept 50 Neo Bladder Augment 50 OncoVEX 50 hematological tumors 50 antiangiogenic activity 50 randomized discontinuation trial 50 CytoFab ™ 50 Phase IIa trial 50 ADAGIO study 50 Janssen Pharmaceutica NV 50 ICA # 50 refractory indolent NHL 50 Replagal 50 chemopreventive agent 50 histologies 50 ganetespib 50 neoplastic diseases 50 Selzentry Celsentri 50 Fanconi syndrome 50 Meda STO MEDAA 50 dimebon latrepirdine 50 Triolex 50 uridine triacetate 50 bavituximab monotherapy trial 50 vaccine Cervarix 50 Hythiam researches develops 50 EC Cysteamine 50 Flutiform ™ 50 Augment Injectable 50 Prodarsan ® 50 Provenge prostate cancer 50 AVN# [001] 50 Stimuvax 50 commercialize XP# 50 gastric pancreatic 50 Telintra 50 pancreatic islet cell 50 fipamezole 50 vascular disrupting agent 50 Desmoteplase 49 FACTIVE tablets 49 Portola Pharmaceuticals 49 #D#C# 49 Cethrin R 49 VentiRx 49 Gaboxadol 49 figitumumab 49 RGB # 49 Fumapharm 49 undergoing hematopoietic stem 49 Increlex 49 lung cancer NSCLC 49 miRNA biomarkers 49 PXD# 49 crofelemer 49 Innovive Pharmaceuticals 49 bilastine 49 cardio renal 49 NASDAQ BTRX pharmaceutical 49 hematological indications 49 Intercell vaccine 49 commercialize AzaSite 49 COMT inhibitors 49 Zor Pharmaceuticals 49 muscular dystrophy cystic fibrosis 49 tafluprost 49 TNF blocking 49 anticancer therapeutics 49 TaiGen 49 recombinant interferon 49 TRACON Pharmaceuticals Inc. 49 refractory CTCL 49 Synerx 49 oral rotavirus vaccine 49 CytoFabTM 49 AFRS TM 49 oral anticancer 49 paliperidone ER 49 oral antiviral 49 coagulation disorders 49 zileuton 49 Alligator Bioscience AB 49 indolent NHL 49 adrenergic regulation 49 registrational trials 49 pneumococcal conjugate vaccine PCV7 49 ALK inhibitors 49 heavily pretreated patients 49 midstage clinical trials 49 iclaprim 49 Wellstat Therapeutics 49 Cougar Biotechnology Inc. 49 tivozanib AV 49 SAR# [004] 49 TransVax 49 p# inhibitor 49 MEDRAD INC. 49 synthetic retinoid 49 KIACTA ™ 49 lipid lowering therapies 49 genotypic resistance 49 GLP toxicology studies 49 MolecularMD 49 Vasovist 49 Cephalon Oncology 49 TransVax ™ 49 Surfaxin LS 49 Nuron Biotech 49 topical PTH #-# 49 almorexant 49 InfaCare Pharmaceutical Corporation 49 SEPET TM 49 anti CD3 monoclonal 49 Preclinical studies suggest 49 AA amyloidosis 49 Salmedix 49 neurogenic bladder 49 Chrysalin 49 Sonolith i move 49 ZYBRESTAT fosbretabulin 49 SMT C# 49 ORTHOVISC mini 49 bosutinib 49 Dacetuzumab 49 ProLindac TM 49 Zenyaku Kogyo 49 dirucotide 49 mg/m2 cohort 49 virus HBV infection 49 molecular imaging radiopharmaceuticals 49 EGRIFTA ™ 49 Xerese 49 DNA methylation biomarkers 49 ASG 5ME 49 anticoagulant reversing agent 49 inhaled cyclosporine 49 darbepoetin alpha 49 BioSTAR R 49 Neuromed Pharmaceuticals Ltd. 49 mGluR5 PAM 49 PresbyLens ® 49 cancer vaccine Norelin 49 Clovis Oncology 48 daclizumab 48 midstage studies 48 heavily pretreated 48 Adhibit 48 Provecta 48 apremilast 48 topical anti infective 48 MyVax personalized immunotherapy 48 novel antibody therapeutics 48 compound COTI 48 unresectable recurrent 48 ImmuPharma 48 Cetrotide R cetrorelix 48 Nasdaq HALO biopharmaceutical 48 Lumacan 48 vascular urology 48 Pancreate 48 Severe VOD 48 targeted immunotherapies 48 triphendiol 48 novel immunotherapies 48 ZARS Pharma 48 Ergomed 48 ThGRF 48 ENTEREG ® 48 maribavir 48 photodisinfection 48 Genetronics 48 biosurgical 48 IIa trial 48 ASONEP 48 DuraTech BioRegeneration Matrix 48 Phase 2a trial 48 See BioWorld Today 48 Cutanea Life Sciences 48 Santen Pharmaceutical Co. 48 Heplisav 48 isavuconazole 48 intravenous bisphosphonates 48 Uracyst ® 48 antidiabetic medications 48 Allovectin 7 R 48 Lorianne Masuoka MD 48 Antizol 48 Azixa 48 Prodarsan 48 class mGluR5 inhibitor 48 MetMAb 48 anticancer activity 48 cosmetic cosmeceutical products 48 AdhTAP 48 thrombolytic agents 48 NOVN.VX Quote Profile Research 48 pexiganan 48 OROS R Hydromorphone 48 HepaGam B TM 48 NeoDisc 48 nonclinical studies 48 PRIMO CABG 48 Cinryze ™ 48 oncology indications 48 overlapping toxicities 48 Subgroup analyzes 48 Bayer HealthCare AG 48 antiresorptive 48 HPV subtypes 48 liposomal ciprofloxacin 48 Alfa Wassermann SpA 48 Broncus Technologies 48 Arsenic trioxide 48 drug Amevive 48 immuno inflammatory diseases 48 non selective NSAIDs 48 Archemix Corp. 48 TOPICA